Foscarnet therapy for AIDS-related opportunistic herpesvirus infections

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

HIV clinical trials·2009

The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.

HIV clinical trials·2005

AIDS-related cytomegalovirus retinitis.

Drugs of today (Barcelona, Spain : 1998)·2004

Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors.

Neuroscience·2002

Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.

HIV clinical trials·2001

Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium.

American journal of physiology. Heart and circulatory physiology·2001

Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy.

AIDS clinical review·2000

Pediatric human immunodeficiency virus type 1 infection: updates on prevention and management.

AIDS clinical review·2000

Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.

AIDS clinical review·1997

Cytokines and cytokine therapies in HIV infection.

AIDS clinical review·1997

Pediatric HIV disease: new developments in treatment and prevention.

AIDS clinical review·1997

The epidemiology of HIV and AIDS in the United States.

AIDS clinical review·1997

A case of tic improvement following tipepidine administration in a boy with Tourette syndrome comorbid with attention-deficit/hyperactivity disorder and autism spectrum disorder.

PCN reports : psychiatry and clinical neurosciences·2026

Subcutaneous MG1113 in severe hemophilia A and B: phase 1b study for safety, pharmacokinetics, and pharmacodynamics.

Research and practice in thrombosis and haemostasis·2026

Efficacy and safety of different TPO-RAs combined with cyclosporine in the treatment of NSAA.

Therapeutic advances in hematology·2026

Mesenchymal Stem Cell-Derived Extracellular Vesicles Ameliorate NaIO3-Induced Dry AMD by Delivering miR-486-3p to Inhibit Lipocalin-2-Mediated Ferroptosis.

MedComm·2026

Effectiveness and safety of telitacicept in refractory ocular myasthenia gravis: a retrospective, real-world study.

Frontiers in immunology·2026

Agomelatine as augmentation therapy with second-generation antipsychotics for negative symptoms of schizophrenia: An open-label randomised clinical trial and electroencephalogram-derived model for treatment response prediction.

General psychiatry·2026

Related Experiment Videos

Foscarnet therapy for AIDS-related opportunistic herpesvirus infections

Related Concept Videos

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.

AIDS-related cytomegalovirus retinitis.

Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors.

Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.

Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium.

Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy.

Pediatric human immunodeficiency virus type 1 infection: updates on prevention and management.

Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.

Cytokines and cytokine therapies in HIV infection.

Pediatric HIV disease: new developments in treatment and prevention.

The epidemiology of HIV and AIDS in the United States.

A case of tic improvement following tipepidine administration in a boy with Tourette syndrome comorbid with attention-deficit/hyperactivity disorder and autism spectrum disorder.

Subcutaneous MG1113 in severe hemophilia A and B: phase 1b study for safety, pharmacokinetics, and pharmacodynamics.

Efficacy and safety of different TPO-RAs combined with cyclosporine in the treatment of NSAA.

Mesenchymal Stem Cell-Derived Extracellular Vesicles Ameliorate NaIO3-Induced Dry AMD by Delivering miR-486-3p to Inhibit Lipocalin-2-Mediated Ferroptosis.

Effectiveness and safety of telitacicept in refractory ocular myasthenia gravis: a retrospective, real-world study.

Agomelatine as augmentation therapy with second-generation antipsychotics for negative symptoms of schizophrenia: An open-label randomised clinical trial and electroencephalogram-derived model for treatment response prediction.

Related Experiment Videos

Foscarnet therapy for AIDS-related opportunistic herpesvirus infections

Related Concept Videos

Related Articles